Previous 10 | Next 10 |
Source : ClearBridge Investments Editor's Note : The summary bullets for this article were chosen by Read more ...
Amid widespread uncertainty in healthcare around COVID-19 impact, Baird is focusing on clinical catalysts that continue to power biotech picks - and in particular it's declaring fresh picks on two stocks with data forthcoming. More news on: Constellation Pharmaceuticals, Inc., Blueprint Me...
After its stock reached all-time highs in February, Galapagos (NASDAQ: GLPG) saw those gains disappear. Don't fret, though. The stock price is down less than 1% year to date -- a decrease many investors, and companies, can only dream of in the current environment. Is Galapagos's lack of pri...
Ultragenyx (NASDAQ: RARE ) inks an agreement with Daiichi Sankyo ( OTCPK:DSKYF ) for its proprietary AAV-based gene therapy manufacturing technologies. More news on: Ultragenyx Pharmaceutical Inc., Daiichi Sankyo Company, Limited, Daiichi Sankyo Company, Limited, Healthcare stocks news, ...
Daiichi Sankyo granted non-exclusive license to Ultragenyx HeLa manufacturing platform Ultragenyx to receive $200 million upfront, including $125 million in cash and $75 million via equity investment NOVATO, Calif., March 31, 2020 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc....
REGENXBIO (NASDAQ: RGNX ) inks an agreement with Ultragenyx (NASDAQ: RARE ) aimed at developing a gene therapy for an undisclosed rare metabolic disorder. More news on: REGENXBIO Inc., Ultragenyx Pharmaceutical Inc., Healthcare stocks news, Read more ...
- REGENXBIO grants Ultragenyx exclusive, worldwide rights to NAV AAV8 and AAV9 Vectors for the development and commercialization of gene therapy treatments for a rare metabolic disorder - Agreement for use of NAV Vectors expands ongoing relationship between Ultragenyx and REGENXBIO RO...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
SARASOTA, Fla. and NOVATO, Calif., March 16, 2020 (GLOBE NEWSWIRE) -- GeneTx Biotherapeutics LLC and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare diseases, today ...
NOVATO, Calif., March 09, 2020 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, today announced that Shalini Sharp, the company's Chief Financial Offi...
News, Short Squeeze, Breakout and More Instantly...
Ultragenyx Pharmaceutical Inc. Company Name:
RARE Stock Symbol:
NASDAQ Market:
Ultragenyx Pharmaceutical Inc. Website:
NOVATO, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultrarare genetic diseases, today announced that it will host a conference call at 5...
NOVATO, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that the company will share the latest clinical data, regulatory progress and program next steps for GTX-102, its investigational antisense oligonucleotide for Angelman syndrome, on Wed...
2024-07-24 04:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...